Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (131-140 of 322) with videos related to

Pageof 33
Sort By:
Human Immunology|December 18, 2007
The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosisAnn B Begovich, Monica Chang, Stacy J Caillier, et al.
Annals of Neurology|October 17, 2020
Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?Christian Cordano, Hao H Yiu, Frederike C Oertel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2023
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extensionStephen L Hauser, Ronald Zielman, Ayan Das Gupta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsColm Elliott, Jerry S Wolinsky, Stephen L Hauser, et al.
American Journal of Human Genetics|December 8, 2004
The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosisAnn B Begovich, Stacy J Caillier, Heather C Alexander, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trialsGavin Giovannoni, Ludwig Kappos, Jerome de Seze, et al.
Annals of Neurology|January 13, 2018
Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout diseaseChristina J Azevedo, Steven Y Cen, Sankalpa Khadka, et al.
Annals of Neurology|January 23, 2014
Quo vadis? Peering into the futureStephen L Hauser, S Claiborne Johnston, Donna M Ferriero, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 2, 2019
Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter AreasNico Papinutto, Carlo Asteggiano, Antje Bischof, et al.
Human Molecular Genetics|December 3, 2005
Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15James A Traherne, Lisa F Barcellos, Stephen J Sawcer, et al.
Pageof 33

Showing results (131-140 of 322) with videos related to

Sort By:
Pageof 33
Human Immunology|December 18, 2007
The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosisAnn B Begovich, Monica Chang, Stacy J Caillier, et al.
Annals of Neurology|October 17, 2020
Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?Christian Cordano, Hao H Yiu, Frederike C Oertel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2023
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extensionStephen L Hauser, Ronald Zielman, Ayan Das Gupta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsColm Elliott, Jerry S Wolinsky, Stephen L Hauser, et al.
American Journal of Human Genetics|December 8, 2004
The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosisAnn B Begovich, Stacy J Caillier, Heather C Alexander, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trialsGavin Giovannoni, Ludwig Kappos, Jerome de Seze, et al.
Annals of Neurology|January 13, 2018
Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout diseaseChristina J Azevedo, Steven Y Cen, Sankalpa Khadka, et al.
Annals of Neurology|January 23, 2014
Quo vadis? Peering into the futureStephen L Hauser, S Claiborne Johnston, Donna M Ferriero, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 2, 2019
Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter AreasNico Papinutto, Carlo Asteggiano, Antje Bischof, et al.
Human Molecular Genetics|December 3, 2005
Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15James A Traherne, Lisa F Barcellos, Stephen J Sawcer, et al.
Pageof 33